Downloads provided by UsageCounts
handle: 10261/76406
[ES] La presente invención se refiere a un compuesto de fórmula (1) derivado de maleimida y con capacidad de inhibir la enzima GSK-3 en rangos micro y nanomolar de forma reversible o irreversible. La presente invención también se refiere al uso de estos compuestos para la fabricación de un medicamento para el tratamiento y/o prevención de enfermedades en la que GSK-3 esté implicada, tales como, enfermedades neurodegenerativas, enfermedades inflamatorias, cáncer o diabetes. Estos compuestos también son útiles para promover procesos regenerativos de diversos tejidos.
[EN] The present invention relates to a compound of formula (1) derived from aleimide and that has the ability to reversibly or irreversibly inhibit the GSK-3 enzyme in the micro- and nanomolar ranges. The present invention likewise relates to the use of these compounds for producing a drug for treating and/or preventing diseases in which GSK-3 is implicated, such as neurodegenerative diseases, inflarnmatory diseases, cancer or diabetes. These compounds can also be used to promote regenerative processes in various tissues.
Consejo Superior de Investigaciones Científicas, Universidad de Barcelona
A1 Solicitud de patente con informe sobre el estado de la técnica
Peer reviewed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 33 | |
| downloads | 37 |

Views provided by UsageCounts
Downloads provided by UsageCounts